Jonathan Stuart Kaplan

Array ( [id] => 7591149 [patent_doc_number] => 07662939 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-02-16 [patent_title] => 'Molecular determinants of tropism and virulence in enteroviruses' [patent_app_type] => utility [patent_app_number] => 10/048709 [patent_app_country] => US [patent_app_date] => 2000-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13211 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662939.pdf [firstpage_image] =>[orig_patent_app_number] => 10048709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740319 [patent_doc_number] => 20030157688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use' [patent_app_type] => new [patent_app_number] => 09/482682 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 41304 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157688.pdf [firstpage_image] =>[orig_patent_app_number] => 09482682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856392 [patent_doc_number] => 07374766 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-20 [patent_title] => 'Compositions containing virus-like particles as immunopotentiators administered through the mucosa' [patent_app_type] => utility [patent_app_number] => 09/857402 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4089 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/374/07374766.pdf [firstpage_image] =>[orig_patent_app_number] => 09857402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609765 [patent_doc_number] => 07151172 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-12-19 [patent_title] => 'Attenuated vif DNA immunization cassettes for genetic vaccines' [patent_app_type] => utility [patent_app_number] => 09/486625 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 13505 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/151/07151172.pdf [firstpage_image] =>[orig_patent_app_number] => 09486625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837117 [patent_doc_number] => 07393933 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-01 [patent_title] => 'Hepatitis B monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 09/402282 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13491 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393933.pdf [firstpage_image] =>[orig_patent_app_number] => 09402282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550310 [patent_doc_number] => 08062642 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-11-22 [patent_title] => 'Production of papillomavirus capsid protein and virus-like particles' [patent_app_type] => utility [patent_app_number] => 08/028517 [patent_app_country] => US [patent_app_date] => 1993-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7888 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/062/08062642.pdf [firstpage_image] =>[orig_patent_app_number] => 08028517 [rel_patent_id] =>[rel_patent_doc_number] =>)